Testicular Cancer of Endodermal Breasts in Infants.
DOI:
https://doi.org/10.54212/27068048.v5i1.82Keywords:
Testicular tumors, Germ cells tumours, Yolk salkAbstract
A rare case is present in a male patient aged 1 year and 2 months, who starts with an increase in the volume of the left testicle, which is diagnosed by ultrasound with the presence of left testicular mass and was taken to the operating room for left radical orchiectomy. In later anatomopathological studies, they report testicular neoplasm of endodermal sinuses.
Testicular germ cell neoplasms are derived from primordial germ cells, which in early embryonic life migrate from the primitive central nervous system to its posterior location at the level of the gonads. They are tumors of unknown cause and represent 95% of testicular tumors. These tumors are also known as embryonal carcinoma of the infant or yolk sac, present more frequently in infants and children up to 3 years and much less frequently until age 5, have an incidence of 6 per 100,000 in men and with Predominance in white race (ratio 5: 1). For its diagnosis one must take into account the aspects: clinical, that is realized with the finding of a solid testicle or intrascrotal mass, mainly without presence of pain and when examining of firm consistency, well defined and mobile; Humoral in the accomplishment and determination of serum tests of alpha fetus protein, chorionic gonadotropin hormone and lactate dehydrogenase, extremely important for our prognostic evaluation and response to established treatment; Radiological, the main study of great utility is the ultrasound that allows us to assess dimensions of the testicle and the tumor, as well as characteristics of the contralateral testicle; The tomographic studies of the pelvis and thorax are supportive to classify their staging and evaluate treatment and, finally, histologically, the histological confirmation of the tumor by pathology. The literature reports survival range that is related to age, however there are survival rates of 96% after chemotherapy. These types of germ cell neoplasms are very aggressive and capable of producing extensive metastases, however, due to scientific advances and the evolution in medical treatments the prognosis has improved due to its multidisciplinary management.
Downloads
References
Wein AJ, Kavoussi LR, Novick AC. Campbell-Walsh. 10a ed. Philadelphia: Saunders Elsevier Inc. United States of America; 2012. Cap 31. p 837-849.
Bazán AA, González AA, Antón LM. Tratado de Tumores Genitourinarios. 1ª ed. Madrid: Ergón España; 2011. Cap 15. p 295-305. https://doi.org/10.1016/S1636-5410(11)71129-1 DOI: https://doi.org/10.1016/S1636-5410(11)71128-X
Gearhart JP, Rink RC, Mouriquand PD. Pediatric Urology. 2a ed. Philadelphia: Saunders Elsevier Inc. United States of America; 2010. Cap 52. p 694-701.
Stringer MD, Oldham KT, Mouriquand PD. Pediatric Sourgery and Urology. 2a ed. Cambridge: Cambridge University Press. United Kingdom. 2006. Cap 56. p 707-720.
Novick AC, Jones JC, Gill IS. Operative Urology at the Cleveland Clinic. 1a ed. New Jersey: Humana Press. United State of America. 2006. Cap 50. p 530-533. https://doi.org/10.1007/978-1-59745-016-4 DOI: https://doi.org/10.1007/978-1-59745-016-4
European Association of Urology Guidelines. 2017 ed. Cap Testicular Cancer. p 5-36.
Bobadilla PV, Tejocote I, Rizzo T. Tumor de senos endodérmicos reporte de un caso. Investigación Materno Infantil. 2012 May - Ago; IV (2): 95-101.
Bujons A, Caffaratti J, Pascual M. Tumores Testiculares en la Infancia. Actas Urológicas Españolas. 2011 Ene; 35 (2): 93-98.
https://doi.org/10.1016/j.acuro.2010.09.005 DOI: https://doi.org/10.1016/j.acuro.2010.09.005
De Backer A, Madern GC, Wolffenbuttel KP. Testicular Germ Cell Tumors in Children: Management and Outcome in a Serie of 20 Patients. Journal of Pediatric Urology. 2006 Oct; 2: 197-201. https://doi.org/10.1016/j.jpurol.2005.08.001 DOI: https://doi.org/10.1016/j.jpurol.2005.08.001
Gantham EC, Caldwell BT, Cost NG. Current Urologic Care for Testicular Germ cell Tumors in a Pediatric and Adolescent Patients. Urologic Oncology. 2016 Jun; 34:65-75. https://doi.org/10.1016/j.urolonc.2015.06.008 DOI: https://doi.org/10.1016/j.urolonc.2015.06.008
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Javier Alejandro Brañas Jurado, Erick Stanley Petersen Juárez, Carlos Brisbane Salazar Monterroso, Sergio Guillermo Pérez Chun, Roberto Orozco, Marisol Gramajo, Alina Fortuny
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
